BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9125803)

  • 1. Interleukin-1 receptor antagonism.
    Nikolic-Paterson DJ; Lan HY; Atkins RC
    Semin Nephrol; 1996 Nov; 16(6):583-90. PubMed ID: 9125803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glomerular expression of interleukin-1 receptor antagonist and interleukin-1 beta genes in antibody-mediated glomerulonephritis.
    Tam FW; Smith J; Cashman SJ; Wang Y; Thompson EM; Rees AJ
    Am J Pathol; 1994 Jul; 145(1):126-36. PubMed ID: 8030744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interleukin-1 receptor antagonist and its delivery by gene transfer.
    Evans CH; Robbins PD
    Receptor; 1994; 4(1):9-15. PubMed ID: 8038709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of interleukin-1 in host responses to infectious diseases.
    Dinarello CA
    Infect Agents Dis; 1992 Oct; 1(5):227-36. PubMed ID: 1344662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The search for inhibitors of interleukin-1 based on the sequence of interleukin-1 receptor antagonist.
    Wieczorek Z; Kluczyk A; Slon-Usakiewicz JJ; Siemion IZ
    Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(4):123-9. PubMed ID: 9575352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data.
    Bendele A; McAbee T; Sennello G; Frazier J; Chlipala E; McCabe D
    Arthritis Rheum; 1999 Mar; 42(3):498-506. PubMed ID: 10088773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of the interleukin-1 receptor following traumatic brain injury in the mouse reduces the number of nitric oxide synthase-2-positive cells and improves anatomical and functional outcomes.
    Jones NC; Prior MJ; Burden-Teh E; Marsden CA; Morris PG; Murphy S
    Eur J Neurosci; 2005 Jul; 22(1):72-8. PubMed ID: 16029197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1 receptor antagonist intervenes in signaling between different types of synoviocytes in rats with adjuvant arthritis.
    Zheng YQ; Wei W; Dai M; Zhu L; Jia XY; Wang Y
    Acta Pharmacol Sin; 2006 Jan; 27(1):111-8. PubMed ID: 16364217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-1 and interleukin-1 receptor antagonist.
    Dinarello CA
    Nutrition; 1995; 11(5 Suppl):492-4. PubMed ID: 8748206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-1 regulates in vivo C-X-C chemokine induction and neutrophil sequestration following endotoxemia.
    Calkins CM; Bensard DD; Shames BD; Pulido EJ; Abraham E; Fernandez N; Meng X; Dinarello CA; McIntyre RC
    J Endotoxin Res; 2002; 8(1):59-67. PubMed ID: 11981446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of interleukin 1 receptor antagonist after interleukin 1 therapy in patients with cancer.
    Kopp WC; Urba WJ; Rager HC; Alvord WG; Oppenheim JJ; Smith JW; Longo DL
    Clin Cancer Res; 1996 Mar; 2(3):501-6. PubMed ID: 9816196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interleukin-1 receptor antagonists in the treatment rheumatoid arthritis].
    Zoń-Giebel A; Kotulska A; Giebel S; Cader SA; Kucharz EJ
    Przegl Lek; 2002; 59(11):916-8. PubMed ID: 12715722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and characterization of IL-1 receptor antagonist in tissues from healthy rabbits: IL-1 receptor antagonist is probably involved in health.
    Matsukawa A; Fukumoto T; Maeda T; Ohkawara S; Yoshinaga M
    Cytokine; 1997 May; 9(5):307-15. PubMed ID: 9195129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
    Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
    Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist.
    Cunha JM; Cunha FQ; Poole S; Ferreira SH
    Br J Pharmacol; 2000 Jul; 130(6):1418-24. PubMed ID: 10903985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 receptor antagonist as an adjunct in the treatment of Haemophilus influenzae otitis media in the chinchilla.
    Kerschner JE; Beste DJ; Lynch JB; Fox MC; Kehl KS
    Laryngoscope; 2000 Sep; 110(9):1457-61. PubMed ID: 10983942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonist.
    Molnar C; Garcia-Trevijano ER; Ludwiczek O; Talabot D; Kaser A; Mato JM; Fritsche G; Weiss G; Gabay C; Avila MA; Tilg H
    Eur Cytokine Netw; 2004; 15(4):303-11. PubMed ID: 15627638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist.
    Dinarello CA
    Int Rev Immunol; 1998; 16(5-6):457-99. PubMed ID: 9646173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.